Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab Basu

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Translational Cancer Research|February 4, 2022
The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscapeVadim S Koshkin, Arnab Basu, Petros Grivas
BMJ Case Reports|March 10, 2019
Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancerJeremy Chang, Jeffrey Tran, Dina Kamel, et al.
Biophysical Chemistry|October 6, 2014
Lipid composition is an important determinant of antimicrobial activity of alpha-melanocyte stimulating hormoneTahsina Shireen, Arnab Basu, Munna Sarkar, et al.
BMJ Case Reports|April 6, 2016
Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapyDebjit Saha, Arnab Basu, Abhishek Maiti, et al.
Vox Sanguinis|March 6, 2003
Hepatitis C virus envelope glycoproteins and potential for vaccine developmentAster Beyene, Arnab Basu, Keith Meyer, et al.
Cancer Journal (Sudbury, Mass.)|September 21, 2013
Palliative care in low- and medium-resource countriesArnab Basu, Barbro Norrström Mittag-Leffler, Kenneth Miller
The Oncologist|August 3, 2024
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directionsKartik R Patel, Soroush Rais-Bahrami, Arnab Basu
Current Protocols in Pharmacology|September 22, 2011
High-throughput screening of viral entry inhibitors using pseudotyped virusArnab Basu, Debra M Mills, Terry L Bowlin
Virology|June 23, 2004
Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivityAster Beyene, Arnab Basu, Keith Meyer, et al.
Journal of Virology|April 14, 2004
The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype systemArnab Basu, Aster Beyene, Keith Meyer, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Translational Cancer Research|February 4, 2022
The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscapeVadim S Koshkin, Arnab Basu, Petros Grivas
BMJ Case Reports|March 10, 2019
Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancerJeremy Chang, Jeffrey Tran, Dina Kamel, et al.
Biophysical Chemistry|October 6, 2014
Lipid composition is an important determinant of antimicrobial activity of alpha-melanocyte stimulating hormoneTahsina Shireen, Arnab Basu, Munna Sarkar, et al.
BMJ Case Reports|April 6, 2016
Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapyDebjit Saha, Arnab Basu, Abhishek Maiti, et al.
Vox Sanguinis|March 6, 2003
Hepatitis C virus envelope glycoproteins and potential for vaccine developmentAster Beyene, Arnab Basu, Keith Meyer, et al.
Cancer Journal (Sudbury, Mass.)|September 21, 2013
Palliative care in low- and medium-resource countriesArnab Basu, Barbro Norrström Mittag-Leffler, Kenneth Miller
The Oncologist|August 3, 2024
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directionsKartik R Patel, Soroush Rais-Bahrami, Arnab Basu
Current Protocols in Pharmacology|September 22, 2011
High-throughput screening of viral entry inhibitors using pseudotyped virusArnab Basu, Debra M Mills, Terry L Bowlin
Virology|June 23, 2004
Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivityAster Beyene, Arnab Basu, Keith Meyer, et al.
Journal of Virology|April 14, 2004
The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype systemArnab Basu, Aster Beyene, Keith Meyer, et al.
Pageof 9